Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 15, 2023

SELL
$1.81 - $8.14 $269,907 - $1.21 Million
-149,120 Reduced 91.21%
14,375 $37,000
Q3 2022

Nov 09, 2022

SELL
$6.54 - $9.08 $32 - $45
-5 Reduced -0.0%
163,495 $1.14 Million
Q2 2022

Aug 17, 2022

SELL
$6.82 - $13.82 $488,618 - $990,133
-71,645 Reduced 30.47%
163,500 $1.12 Million
Q1 2022

May 16, 2022

BUY
$11.65 - $15.28 $40,658 - $53,327
3,490 Added 1.51%
235,145 $3.32 Million
Q4 2021

Feb 15, 2022

BUY
$12.37 - $16.77 $69,655 - $94,431
5,631 Added 2.49%
231,655 $3.36 Million
Q3 2021

Nov 15, 2021

BUY
$13.7 - $17.25 $294,536 - $370,857
21,499 Added 10.51%
226,024 $3.2 Million
Q2 2021

Aug 17, 2021

BUY
$13.75 - $18.8 $429,343 - $587,030
31,225 Added 18.02%
204,525 $3.6 Million
Q1 2021

May 17, 2021

BUY
$11.49 - $19.21 $1.99 Million - $3.33 Million
173,300 New
173,300 $2.65 Million

Others Institutions Holding BVS

About Bioventus Inc.


  • Ticker BVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 61,664,200
  • Market Cap $622M
  • Description
  • Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...
More about BVS
Track This Portfolio

Track Salem Investment Counselors Inc Portfolio

Follow Salem Investment Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Investment Counselors Inc with notifications on news.